These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulatory T cells protect from local and systemic bone destruction in arthritis. Zaiss MM, Frey B, Hess A, Zwerina J, Luther J, Nimmerjahn F, Engelke K, Kollias G, Hünig T, Schett G, David JP. J Immunol; 2010 Jun 15; 184(12):7238-46. PubMed ID: 20483756 [Abstract] [Full Text] [Related]
3. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Zaiss MM, Axmann R, Zwerina J, Polzer K, Gückel E, Skapenko A, Schulze-Koops H, Horwood N, Cope A, Schett G. Arthritis Rheum; 2007 Dec 15; 56(12):4104-12. PubMed ID: 18050211 [Abstract] [Full Text] [Related]
4. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes. Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C. Exp Hematol; 2007 Mar 15; 35(3):416-25. PubMed ID: 17309822 [Abstract] [Full Text] [Related]
5. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. Pyzik M, Piccirillo CA. J Leukoc Biol; 2007 Aug 15; 82(2):335-46. PubMed ID: 17475784 [Abstract] [Full Text] [Related]
6. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y. Transpl Immunol; 2007 Apr 15; 17(3):153-61. PubMed ID: 17331841 [Abstract] [Full Text] [Related]
7. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells. Huber S, Stahl FR, Schrader J, Lüth S, Presser K, Carambia A, Flavell RA, Werner S, Blessing M, Herkel J, Schramm C. J Immunol; 2009 Apr 15; 182(8):4633-40. PubMed ID: 19342638 [Abstract] [Full Text] [Related]
8. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. Aarts-Riemens T, Emmelot ME, Verdonck LF, Mutis T. Eur J Immunol; 2008 May 15; 38(5):1381-90. PubMed ID: 18412171 [Abstract] [Full Text] [Related]
11. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. Lee SK, Kadono Y, Okada F, Jacquin C, Koczon-Jaremko B, Gronowicz G, Adams DJ, Aguila HL, Choi Y, Lorenzo JA. J Bone Miner Res; 2006 Nov 15; 21(11):1704-12. PubMed ID: 17002560 [Abstract] [Full Text] [Related]
12. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. J Exp Med; 2006 Nov 27; 203(12):2673-82. PubMed ID: 17088434 [Abstract] [Full Text] [Related]
13. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Siemasko KF, Gao J, Calder VL, Hanna R, Calonge M, Pflugfelder SC, Niederkorn JY, Stern ME. Invest Ophthalmol Vis Sci; 2008 Dec 27; 49(12):5434-40. PubMed ID: 18658093 [Abstract] [Full Text] [Related]
17. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W. Immunol Lett; 2009 Aug 15; 125(2):105-13. PubMed ID: 19539651 [Abstract] [Full Text] [Related]
18. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo. Delgado M, Chorny A, Gonzalez-Rey E, Ganea D. J Leukoc Biol; 2005 Dec 15; 78(6):1327-38. PubMed ID: 16204628 [Abstract] [Full Text] [Related]
19. Recent thymic origin, differentiation, and turnover of regulatory T cells. Mabarrack NH, Turner NL, Mayrhofer G. J Leukoc Biol; 2008 Nov 15; 84(5):1287-97. PubMed ID: 18682578 [Abstract] [Full Text] [Related]
20. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. Kanazawa K, Kudo A. J Bone Miner Res; 2005 May 15; 20(5):840-7. PubMed ID: 15824857 [Abstract] [Full Text] [Related] Page: [Next] [New Search]